{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:50:23Z","timestamp":1780617023166,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/purpose<\/jats:title>\n                <jats:p>Serpiginous-like choroiditis is a rare immune-mediated sub-entity of tubercular uveitis with a usually deleterious outcome. Treatment is still controversial. The purpose in this case series is to indicate that only aggressive treatment comprising multiple anti-tubercular and multiple immunosuppressive agents seems to be able to halt the disease progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective case series included patients diagnosed with Interferon Gamma Release Assays (IGRA) -positive serpiginous choroiditis, seen at the Centre for Ophthalmic Specialized Care, Lausanne, Switzerland, treated with combined multiple antitubercular and immunosuppressive agents at presentation and having a sufficient follow-up. Disease history before referral, appraisal of disease, treatment modalities and follow-up were analyzed. Inclusion criteria were positive IGRA patients with serpiginous choroiditis with complete Spectral-Domain Optic coherence tomography (SD-OCT) and angiography images.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 2001 to 2020, 24 of 1525 new patients (0.26%) were diagnosed as serpiginous choroiditis. 10\/24 were related to tuberculosis (positive IGRA and\/or hyper-positive Mantoux test), 8\/24 were IGRA negative and in 6 there was no information available. 4\/10 tuberculosis related serpiginous patients fulfilled the inclusion criteria. Mean age was 39\u2009\u00b1\u20095.3\u2009years. Snellen best corrected vision acuity (BCVA) at presentation in 3\/4 where the macula was preserved was 0.96\u2009\u00b1\u20090.08. In 3\/4 patients, treatment with multiple tuberculostatic therapy combined with multiple immunosuppressive agents, started at presentation or in the initial months after the first consultation, was shown to stop the progression of the disease, with a retained visual acuity of 1.0. One patient with macular involvement and a bilateral visual acuity of hand movements after 11\u2009years of insufficient treatment, improved his visual acuity to 0.25 OD and 0.05 OS and presented a substantial visual field improvement that stabilized once multiple anti-tubercular and immunosuppressive therapy was introduced.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>IGRA-positive serpiginous choroiditis (serpiginous-like choroiditis) could be halted by combined multiple tuberculostatic and multiple immunosuppressive agents, as seen in our study where 3\/4 early treated patients had conserved central function and one late treated patient had recovered a substantial amount of visual field. In all 4 patients this treatment regimen halted the progression of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-022-00282-6","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T04:46:07Z","timestamp":1644295567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-5112","authenticated-orcid":false,"given":"Ioannis","family":"Papasavvas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carl P.","family":"Herbort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"issue":"3","key":"282_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/ijo.IJO_822_18","volume":"67","author":"PD Majumder","year":"2019","unstructured":"Majumder PD, Biswas J, Gupta A (2019) Enigma of serpiginous choroiditis. Indian J Ophthalmol 67(3):325\u2013333. https:\/\/doi.org\/10.4103\/ijo.IJO_822_18","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"282_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/diagnostics11060939","volume":"11","author":"CP Herbort Jr","year":"2021","unstructured":"Herbort CP Jr, Mantovani A, Tugal-Tutkun I (2021) Papasavvas I classification of non-infectious and\/or immune mediated choroiditis: a brief overwiew of the essentials. Diagnostics (Basel) 11(6):939. https:\/\/doi.org\/10.3390\/diagnostics11060939","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"282_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1076\/ocii.10.4.253.15585","volume":"10","author":"K Priya","year":"2002","unstructured":"Priya K, Madhavan HN, Reiser BJ, Biswas J, Saptagirish R, Narayama KM, Rao NA (2002) Association of herpesvirus in the aqueous humour of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm 10(4):253\u2013261. https:\/\/doi.org\/10.1076\/ocii.10.4.253.15585","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"282_CR4","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/S0161-6420(03)00619-5","volume":"110","author":"V Gupta","year":"2003","unstructured":"Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A (2003) Presumed tubercular sepiginous-like choroiditis: clinical presentations and management. Ophthalmology 110(9):1744\u20131749. https:\/\/doi.org\/10.1016\/S0161-6420(03)00619-5","journal-title":"Ophthalmology"},{"issue":"11","key":"282_CR5","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.ophtha.2012.05.034","volume":"119","author":"R Bansal","year":"2012","unstructured":"Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P (2012) Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology 119(11):2334\u20132342. https:\/\/doi.org\/10.1016\/j.ophtha.2012.05.034","journal-title":"Ophthalmology"},{"issue":"5","key":"282_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/bjophthalmol-2012-302918","volume":"97","author":"WL Gan","year":"2013","unstructured":"Gan WL, Jones NP (2013) Serpiginous-like choroiditis as a marker for tuberculosis in a non-endemic area. Br J Ophthalmol 97(5):644\u2013647. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302918 Epub 2013 Feb 28. PMID: 23449344","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"282_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/17476348.2014.852471","volume":"8","author":"M Thillai","year":"2014","unstructured":"Thillai M, Pollock K, Pareek M, Lalvani A (2014) Interferon-gamma release assays for tuberculosis: current and future applications. Expert Rev Respir Med 8(1):67\u201378. https:\/\/doi.org\/10.1586\/17476348.2014.852471 Epub 2013 Dec 2. PMID: 24308653","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"282_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10792-011-9508-y","volume":"32","author":"G De Luigi","year":"2012","unstructured":"De Luigi G, Mantovani A, Papadia M, Herbort CP (2012) Tuberculosisrelated choriocapillaritis (multifocal-serpiginous choroiditis) : follow-up and precise monitoring of therapy by indocyanine green angiography. Int Ophthalmol 32(1):55\u201360. https:\/\/doi.org\/10.1007\/s10792-011-9508-y","journal-title":"Int Ophthalmol"},{"key":"282_CR9","doi-asserted-by":"publisher","unstructured":"Tummala GC, Chu Z, Weinstein JE, Wang RK, Pepple KL. Swept source OCTA reveals a link between choriocapillaris blood flow and vision loss in a case of tubercular serpiginous-like choroiditis. Am J Ophthalmol Case Rep. 2021;21:101018. https:\/\/doi.org\/10.1016\/j.ajoc.2021.101018. PMID: 33553805; PMCID: PMC7851177","DOI":"10.1016\/j.ajoc.2021.101018"},{"key":"282_CR10","doi-asserted-by":"publisher","unstructured":"Malamos P, Masaoutis P, Georgalas I, Maselos S, Andrianopoulos K, Koutsandrea C, Markomichelakis NN. The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders. Biomed Res Int. 2015;2015:247469.https:\/\/doi.org\/10.1155\/2015\/247469. Epub 2015 Jan 28. PMID: 25695054; PMCID: PMC4324492","DOI":"10.1155\/2015\/247469"},{"key":"282_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/ICB.0000000000000512","volume":"12","author":"A El Ameen","year":"2018","unstructured":"El Ameen A, Herbort CP Jr (2018) Serpiginous choroiditis imaged by optical coherence tomography angiography. Retin Cases Brief Rep 12:279\u2013285. https:\/\/doi.org\/10.1097\/ICB.0000000000000512","journal-title":"Retin Cases Brief Rep"},{"key":"282_CR12","first-page":"1901","volume":"68","author":"A Shah","year":"2002","unstructured":"Shah A, Rao VG, Verma A, Biswas J (2002) Evaluation of change in vascular density of choriocapillaris on optical coherence tomography angiography in eyes with serpiginous choroiditis. Indian J Ophthalmol 68:1901\u20131904","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"282_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/IAE.0000000000002915","volume":"41","author":"A Agarwal","year":"2021","unstructured":"Agarwal A, Aggarval K, Reddy Mandadi SK, Kumar A, Grewal D, Invernizzi A, Bansal R, Sharma A, Sharma K, Gupta V, OCTA Study Group (2021) Longitudinal follow-up of tubercular serpiginous-like choroiditis using optical coherence tomography angiography. Retina 41(4):793\u2013803. https:\/\/doi.org\/10.1097\/IAE.0000000000002915","journal-title":"Retina"},{"key":"282_CR14","doi-asserted-by":"publisher","unstructured":"Herbort CP Jr, Tugal-Tutkun I, Mantovani A, Neri P, Khairallah M, Papasavvas I. Advances and potential new developments in imaging techniques for posterior uveitis Part 2: invasive imaging methods. Eye (Lond). 2021;35(1):52\u201373. https:\/\/doi.org\/10.1038\/s41433-020-1072-0. Epub 2020 Aug 10. PMID: 32778739; PMCID: PMC7852522","DOI":"10.1038\/s41433-020-1072-0"},{"issue":"6","key":"282_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamaophthalmol.2014.270","volume":"132","author":"H Nazari","year":"2014","unstructured":"Nazari H, Karakousis P, Rao NA (2014) Replication of mycobacterium tuberculosis in retinal pigment epithelium. JAMA Ophthalmol 132(6):724\u2013729. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.270","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"282_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1139\/I06-006","volume":"41","author":"RNG Vianna","year":"2006","unstructured":"Vianna RNG, Ozdal PC, Desch\u00eanes BMN Jr (2006) Conbination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. Can J Ophthalmol 41(2):183\u2013189. https:\/\/doi.org\/10.1139\/I06-006","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"282_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1076\/ocii.9.3.153.3962","volume":"9","author":"EK Akpek","year":"2001","unstructured":"Akpek EK, Baltatzis S, Yang J, Foster CS (2001) Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm 9(3):153\u2013167. https:\/\/doi.org\/10.1076\/ocii.9.3.153.3962","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"282_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/09273940500227192","volume":"14","author":"NN Markomichelakis","year":"2006","unstructured":"Markomichelakis NN, Halkiadakis I, Papaethymiou-Orchan S, Giannakopoulos N, Ekonomopoulos N, Kouris T (2006) Intravenous pulse methylprednisolone therapy for acute treatmemt of serpiginous choroiditis. Ocul Immunol Inflamm 14(1):29\u201333. https:\/\/doi.org\/10.1080\/09273940500227192","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"282_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/09273940701375162","volume":"15","author":"H Abrez","year":"2007","unstructured":"Abrez H, Biswas J, Sudharshavi S (2007) Clinical profile, treatment, and visual outcome of serpiginous choroiditis. Ocul Immunol Inflamm 15(4):325\u2013335. https:\/\/doi.org\/10.1080\/09273940701375162","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"282_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0161-6420(02)01097-7","volume":"109","author":"EK Akpek","year":"2002","unstructured":"Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS (2002) Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 109(8):1506\u20131513. https:\/\/doi.org\/10.1016\/S0161-6420(02)01097-7","journal-title":"Ophthalmology"},{"issue":"2","key":"282_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/09273948.2016.1214737","volume":"26","author":"N Ebrahimiadib","year":"2018","unstructured":"Ebrahimiadib N, Modjtahedi BS, Davoudi S, Foster CS (2018) Treatment of serpiginous choroiditis with chlorambucil: a report of 17 patients. Ocul Immunol Inflamm 26(2):228\u2013238. https:\/\/doi.org\/10.1080\/09273948.2016.1214737","journal-title":"Ocul Immunol Inflamm"},{"key":"282_CR22","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.ajoc.2021.101014","volume":"21","author":"A Maleki","year":"2021","unstructured":"Maleki A, Maldonado Cerda A, Garcia CM, Zein M, Manhapra A, Foster CS (2021) Chlorambucil combination therapy in refractory serpiginous choroiditis: a cure? Am J Ophthalmol Case Rep 21:101014. https:\/\/doi.org\/10.1016\/j.ajoc.2021.101014 eCollection 2021","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"282_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/09273948.2016.1237663","volume":"26","author":"P Venkatesh","year":"2018","unstructured":"Venkatesh P, Tayade A, Gogia V, Gupta S, Shah BM, Vohra R (2018) Short-term intensive immunosuppression: a randomized three-arm study of intravenous pulse methylprednisolone and cyclophosphamide in macular serpiginous choroiditis. Ocul Immunol Inflamm 26(3):469\u2013476. https:\/\/doi.org\/10.1080\/09273948.2016.1237663","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"282_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000321401","volume":"1","author":"OG Sahin","year":"2010","unstructured":"Sahin OG (2010) Long-term cyclophosphamide treatment in a case with serpiginous choroiditis. Case Rep Ophthalmol 1(2):71\u201376. https:\/\/doi.org\/10.1159\/000321401","journal-title":"Case Rep Ophthalmol"},{"issue":"6","key":"282_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0161-6420(91)32198-5","volume":"98","author":"PL Hooper","year":"1991","unstructured":"Hooper PL, Kaplan HJ (1991) Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 98(6):944\u2013951. https:\/\/doi.org\/10.1016\/S0161-6420(91)32198-5","journal-title":"Ophthalmology"},{"issue":"5","key":"282_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/s-2001-15910","volume":"218","author":"F Vonmoos","year":"2001","unstructured":"Vonmoos F, Messerli J, Moser HR, Pr\u00fcnte C, Flammer J, Haefliger IO (2001) Immunosuppressive therapy in serpiginous choroiditis: case report and brief review of the literature. Klin Monatsbl Augenheilkd 218(5):394\u2013397. https:\/\/doi.org\/10.1055\/s-2001-15910","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"8","key":"282_CR27","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1111\/j.1755-3768.2009.01738.x","volume":"88","author":"P Seve","year":"2010","unstructured":"Seve P, Mennesson E, Grange JD, Broussolle C, Kodjikian L (2010) Infliximab in serpiginous choroiditis. Acta Ophthalmol 88(8):e342\u2013e343. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01738.x","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"282_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4274\/tjo.94809","volume":"46","author":"E Esen","year":"2016","unstructured":"Esen E, Sizmaz S, Kunt Z, Demircan N (2016) Paradoxical worsening of tubercular serpiginous-like choroiditis after initiation of antitubercular therapy. Turk J Ophthalmol 46(4):186\u2013189. https:\/\/doi.org\/10.4274\/tjo.94809","journal-title":"Turk J Ophthalmol"},{"key":"282_CR29","doi-asserted-by":"publisher","unstructured":"Ganesh SK, Abraham S, Sudharshan S. Paradoxical reactions in ocular tuberculosis. J Ophthalmic Inflamm Infect. 2019;9(1):19. https:\/\/doi.org\/10.1186\/s12348-019-0183-x. PMID: 31493128; PMCID: PMC6730739","DOI":"10.1186\/s12348-019-0183-x"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-022-00282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-022-00282-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-022-00282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T16:52:53Z","timestamp":1644339173000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-022-00282-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s12348-022-00282-6","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}